In particular, therapeutic targeting of TAZ and YAP by dimethyl fumarate was reported to be effective in preventing bleomycin-induced fibrosis in mice and in blocking the pro-fibrotic effects of TGF-β in cultured SSc skin fibroblasts [182]. The gene discussed is TGFB1; the disease is systemic sclerosis.